This suggests that mutations in the 5′-UTR of ANKRD26 alone are not sufficient to cause malignancy transformation, and other genetic abnormalities or environmental factors are needed to trigger the development of hematological malignancy. This evidence concerns the gene ANKRD26 and hematologic disorder.